How many patents does
Oregon Health And Science University have?
patents
1,720
families
355
granted
353
applications
1,367
US
630
WO
287
EP
277
JP
67
CN
42
KR
16
GB
7
RoW
394
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Oregon Health And Science University
Top ten assignees appearing on patents
2009 - 2018
| athersys | 28 |
| cook medical technologies | 27 |
| abt holding company | 26 |
| cook | 21 |
| tan, ou | 18 |
| novartis | 18 |
| cook biotech | 18 |
| medvet science | 16 |
| medicines for malaria venture | 12 |
| biorest | 11 |
2009
| cook | 12 |
| novartis | 7 |
| medvet science | 5 |
| abt holding company | 4 |
| roche lestienne, catherine | 4 |
| cook biotech | 3 |
| roche | 3 |
| william cook europe | 2 |
| med institute | 2 |
| dnar | 2 |
Oregon Health And Science University
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| multipotent adult stem cells and methods for isolation | 47 | 1999 |
| methods for detecting a mycobacterium tuberculosis infection | 45 | 2006 |
| recombinant hcmv and rhcmv vectors and uses thereof | 42 | 2010 |
| immunomodulatory properties of multipotent adult progenitor cells and uses thereof | 31 | 1999 |
| pyy3-36 for the reduction or prevention of obesity | 24 | 2001 |
| methods for producing an immune response to tuberculosis | 23 | 2009 |
| anti-factor xi monoclonal antibodies and methods of use thereof | 23 | 2007 |
| sobetirome in the treatment of myelination diseases | 21 | 2013 |
| cmv glycoproteins and recombinant vectors | 19 | 2010 |
| mutated abl kinase domains | 19 | 2001 |